UK planning laws deter investment, says drugs giant [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Dave Ricks, chief executive of the obesity drug manufacturer Eli Lilly, said he had considered building a factory in the UK in the last decade, but chose another country instead. He warned current planning processes were an "impediment" to building factories at speed, unlike in the US and Ireland. "Mostly what they do is they pre-reserve land, they promise to cut through the red tape and layers of government," Mr Ricks said. Eli Lilly, along with its Danish rival Novo Nordisk, has developed a considerable lead over the rest of the pharmaceutical industry when it comes to obesity medication. Its drugs, which include Zepbound and Mounjaro, are in such demand that the company cannot build factories quickly enough. The country has operations in the US, Ireland and other European Union countries including Italy, France and Germany. Mr Ricks said countries that "could present a path" in which the time taken to set up a pharmaceutical plant was reduced from five years to two was
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- C2N Diagnostics Says FDA's Approval of Donanemab Highlights Its Role in Helping to Determine Alzheimer's Disease Pathology [Yahoo! Finance]Yahoo! Finance
- South Florida expert on what you need to know about new Alzheimer's drug [CBS News]CBS News
- FDA approves new drug for Alzheimer's disease: ‘Meaningful results' [FOX News]FOX News
- FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S. [MSNBC.com]MSNBC.com
- ALZHEIMER'S DRUG DISCOVERY FOUNDATION (ADDF) STATEMENT ON FDA'S TRADITIONAL APPROVAL OF KISUNLA (DONANEMAB) [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 7/2/24 - Form 4
- 7/1/24 - Form 4
- 6/28/24 - Form 144
- LLY's page on the SEC website